Carillon® by Cardiac Dimensions is an indirect mitral annuloplasty system. Explore its design, the clinical context and the questions that support a complete structural heart product evaluation.
Education Discuss your structural heart programmeCardiac Dimensions · Structural Heart · Mitral Repair
An indirect annuloplasty approach to secondary mitral regurgitation. Carillon uses the coronary venous anatomy to reshape the mitral apparatus, with proximal and distal anchors joined by a shaping ribbon.
The right-heart catheter approach does not require transseptal puncture. The manufacturer describes assessment of implant position, safety and mitral regurgitation before release, with recapture possible while the implant remains connected.
The published English IFU indicates Carillon for symptomatic secondary (functional) mitral regurgitation, NYHA class ≥2, despite guideline-directed medical therapy. Selection belongs to a specialised multidisciplinary Heart Team.
Start the discussion with the clinical problem your service wants to address. Ask the presenter to explain the device mechanism on an anatomical model, identify the anchors and shaping ribbon, and show how the proposed system fits your team’s existing assessment pathway.
For technical and purchasing teams, request a written configuration list, traceability requirements and a clear support plan. Keep the proposed equipment, disposable components and training arrangements together in the evaluation.
The current Italian IFU LAB-1505-06AN, issued 17 June 2026, contraindicates existing devices in the coronary sinus/great cardiac vein, except CRT leads implanted at least six months earlier. Patients treated with Carillon in the presence of such a CRT lead must be monitored for malfunction or structural defects of either device. Previous mitral valve replacement or a mitral annuloplasty ring remains a contraindication. Permanent implantation may affect future coronary sinus interventions or pacing-lead placement. Discuss future treatment plans during assessment.
Use the manufacturer’s current clinical documentation to review risks and applicability. A product demonstration explains the technology; it cannot establish eligibility for an individual patient or guarantee a clinical result.
Ask for a structural heart product discussion, a configuration review or a team demonstration. Tell us who needs to attend and what the session should resolve, so the discussion supports a practical purchasing and education decision.
Reviewed 7 October 2026: Cardiac Dimensions healthcare-professional information and Italian documents and IFU in Education. Match the supplied device and current local instructions before use.
